<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52374">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02424357</url>
  </required_header>
  <id_info>
    <org_study_id>20150111</org_study_id>
    <nct_id>NCT02424357</nct_id>
  </id_info>
  <brief_title>Suture Contamination Rate in Adjustable Suture Strabismus Surgery</brief_title>
  <official_title>Suture Contamination Rate in Adjustable Suture Strabismus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bascom Palmer Eye Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bascom Palmer Eye Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To establish the culture positivity rate in adjustable suture strabismus surgery

        2. To identify bacterial species and antibiotic susceptibility patterns of microorganisms
           cultured from suture material

        3. To compare suture contamination rates with techniques to reduce the suture
           contamination rate
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>culture positivity rate in adjustable suture strabismus surgery</measure>
    <time_frame>6 months</time_frame>
    <description>1 cm section of the suture proximal to the knot will be harvested and placed in a tube with 2 ml of trypticase soy broth (TSB).The TSB tubes will be monitored for growth of bacteria at 48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-operative 5%povidone iodine to reduce contamination rate (compare suture contamination rates with techniques)</measure>
    <time_frame>6 months</time_frame>
    <description>To compare suture contamination rates with techniques to reduce the suture contamination rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify bacterial species and antibiotic susceptibility patterns of microorganisms cultured from suture material</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Suture Strabismus Surgery</condition>
  <arm_group>
    <arm_group_label>postoperative 5%povidone iodine eye drop with ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>routine antibiotic/steroid ointment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5%povidone iodine ophthalmic solution</intervention_name>
    <description>At the conclusion of the surgery, all patients will receive a strip of ophthalmic ointment containing antibiotics and corticosteroids into the conjunctival fornix. The subjects will then be randomized (use computer program to generate random digit) into two groups:
Group 1: Patients will receive one drop of 5% povidone iodine instilled into the conjunctival fornix.
Group 2: Patients will not receive 5% povidone iodine into conjunctival fornix.</description>
    <arm_group_label>postoperative 5%povidone iodine eye drop with ointment</arm_group_label>
    <other_name>5%Betadine ophthalmic drop</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All strabismus patients age â‰¥ 18 years scheduled for strabismus surgery with
             adjustable sutures at the Bascom Palmer Eye Institute will be invited to participate.

        Exclusion Criteria:

          -  Patient who has a history of allergy to povidone-iodine.

          -  Disorders affecting immune function.

          -  Patient who is unwilling to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hilda Capo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bascom Palmer Eye Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bascom Palmer Eye Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Eustis HS, Rhodes A. Suture contamination in strabismus surgery. J Pediatr Ophthalmol Strabismus. 2012 Jul-Aug;49(4):206-9. doi: 10.3928/01913913-20110920-01.</citation>
    <PMID>22909077</PMID>
  </reference>
  <reference>
    <citation>Olitsky SE, Vilardo M, Awner S, Reynolds JD. Needle sterility during strabismus surgery. J AAPOS. 1998 Jun;2(3):151-2.</citation>
    <PMID>10532751</PMID>
  </reference>
  <reference>
    <citation>Carothers TS, Coats DK, McCreery KM, Rossman SN, Wilson P, Wu TG, Paysse EA. Quantification of incidental needle and suture contamination during strabismus surgery. Binocul Vis Strabismus Q. 2003;18(2):75-9.</citation>
    <PMID>12765540</PMID>
  </reference>
  <reference>
    <citation>Apt L, Isenberg SJ, Yoshimori R, Chang A, Lam GC, Wachler B, Neumann D. The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol. 1995 Jun;119(6):701-5.</citation>
    <PMID>7540363</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 2, 2017</lastchanged_date>
  <firstreceived_date>April 20, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bascom Palmer Eye Institute</investigator_affiliation>
    <investigator_full_name>Sirinya Suwannaraj</investigator_full_name>
    <investigator_title>Research fellow</investigator_title>
  </responsible_party>
  <keyword>Adjustable strabismus surgery</keyword>
  <keyword>suture contamination</keyword>
  <keyword>5%povidone iodine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Strabismus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Cadexomer iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
